Skip to main content
SpringerLink
Log in

OCT in Toxic and Nutritional Optic Neuropathies

  • Chapter
  • First Online:
OCT and Imaging in Central Nervous System Diseases

Abstract

Despite the recent developments of OCT in neuro-ophthalmology, its use for diagnosing and monitoring nutritional and toxic optic neuropathies is still limited, due to the lack of powered, longitudinal studies. Small series have suggested that OCT may be useful in various toxic optic neuropathies in the acute stage, disclosing subtle retinal nerve fibre layer thickening, ophthalmoscopically undetectable. At later stages, retinal nerve fibre layer thinning affects the papillomacular bundle, and then, all quadrants, but only rarely before visual loss. Macular volume OCT studies have suggested that in toxic optic neuropathies, the primary site of injury may involve the retinal ganglion cells layers. Retinal nerve fibre layer thinning in the nasal quadrant in patients treated with vigabatrin appears to be predictive of visual field constriction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Grzybowski A, Zulsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93:402–10. https://doi.org/10.1111/aos.12515.

    Article  PubMed  Google Scholar 

  2. Wang MY, Sadun AA. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013;33:172–8.

    Article  CAS  PubMed  Google Scholar 

  3. Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005;243:410–6.

    Article  PubMed  Google Scholar 

  4. Sihota R, Sony P, Gupta V, et al. Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Invest Ophthalmol Vis Sci. 2006;47:2006–10.

    Article  PubMed  Google Scholar 

  5. Rebolleda G, Noval S, Contreras I, et al. Optic disc cupping after optic neuritis evaluated with optic coherence tomography. Eye (Lond). 2008;23:890–4.

    Google Scholar 

  6. Medeiros FA, Moura FC, Vessani RM, Susanna R. Axonal loss after traumatic optic neuropathy documented by optical coherence tomography. Am J Ophthalmol. 2003;135:406–8.

    Article  PubMed  Google Scholar 

  7. Fisher JB, Jacobs DA, Markowitz CF, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324–32.

    Article  PubMed  Google Scholar 

  8. Kozak SF, Inderlied CB, Hsu HY, et al. The role of copper on ethambutol’s antimicrobial action and implications for ethambutol-induced optic neuropathy. Mycobacteriology. 1998;30:83–7.

    CAS  Google Scholar 

  9. Masvidal D, Parrish RK II, Lam BL. Structural-functional dissociation in presumed ethambutol optic neuropathy. J Neuroophthalmol. 2010;30:305–10.

    Article  PubMed  Google Scholar 

  10. Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. J Neuroophthalmol. 2008;28:265–8.

    Article  PubMed  Google Scholar 

  11. Sivakumaran P, Harrisson AC, Marschner J. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med J. 1998;13:428–30.

    Google Scholar 

  12. Kinoshita J, Iwata N, Maejima T, Kimotsuki T, Yasuda M. Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy. Invest Ophthalmol Vis Sci. 2012;53:7052–62.

    Article  PubMed  Google Scholar 

  13. Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol. 2007;91:895–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kim U, Hwang JM. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol. 2009;19:466–9.

    Article  PubMed  Google Scholar 

  15. Han J, Byun MK, Lee J, Han SY, Lee JB, Han SH. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2015;253:2293–9.

    Google Scholar 

  16. Vieira LM, Silva NF, et al. Retinal ganglion cell layer analysis by optical coherence tomography in toxic and nutritional optic neuropathy. J Neuroophthalmol. 2015;35(3):242–5.

    Article  PubMed  Google Scholar 

  17. Lee JY, Choi JH, Park KA, Oh SY. Ganglion cell layer and inner plexiform layer as predictors of vision recovery in ethambutol-induced optic neuropathy: a longitudinal OCT analysis. Invest Ophthalmol Vis Sci. 2018;59:2104–9.

    Article  CAS  PubMed  Google Scholar 

  18. Kim KL, Park SP. Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level. Cutan Ocul Toxicol. 2016;35:228–32.

    Article  CAS  PubMed  Google Scholar 

  19. Makino S. Utility of optical coherence tomography in the evaluation of patients with ethambutol-induced optic neuropathy. Int J Ophthalmol Vis Sci. 2014;12(1).

    Google Scholar 

  20. Junli X, Qi D, Shuangqing W, Wenyan S, Shanping Z, Liangyu Z. Treatment of ethambutol-induced optic neuropathy by buqihuoxue formula combined with methycobal. Int J Clin Exp Med. 2017;10:7100–15.

    Google Scholar 

  21. Fanta H, Mayer-Obcrditsch L. Ein Bcitrag zur Pathologie im Schncrven bci Methylalkoholvergiftung (Tierversuche). Klin Monatsbl Augenheilkd. 1953;122:288–394.

    Google Scholar 

  22. Sanaei-zadeh H, Zamani N, Shadnia SH. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol (Phila). 2011;49:102–7.

    Article  Google Scholar 

  23. Brent J, McMartin K, Phillips S, Aaron C, Kulig K. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001;344:424–9.

    Article  CAS  PubMed  Google Scholar 

  24. Pakravan M, Sanjari N. Erythropoietin treatment for methanol optic neuropathy. J Neuroophthalmol. 2012;32:325–8.

    Article  PubMed  Google Scholar 

  25. Fujihara M, Kikuchi M, Kurimoto Y. Methanol-induced retinal toxicity patient examined by optical coherence tomography. Jpn J Ophthalmol. 2006;50:239–41.

    Article  PubMed  Google Scholar 

  26. Klein KA, Warren AK, Baumal CR, Hedges TR III. Optical coherence tomography findings in methanol toxicity. Int J Retina Vitreous. 2017;3:36.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nurieva O, Diblik P, Kuthan P, Sklenka P, Meliska M, Bydzovsky J, Heissigerova J, Urban P, Kotikova K, Navratil T, Komarc M, Seidl Z, Vaneckova M, Pelclova D, Zakharov S. Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. Am J Ophthalmol. 2018;191:100–15.

    Article  CAS  PubMed  Google Scholar 

  28. Cullom ME, Heher KL, Miller NR, Savino PJ, Johns DR. Leber’s hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol. 1993;111:1482–5.

    Article  CAS  PubMed  Google Scholar 

  29. Mackey D, Howell N. Tobacco amblyopia. Am J Ophthalmol. 1994;117:817–9.

    Article  CAS  PubMed  Google Scholar 

  30. Johns DR, Heher KL, Miller NR, Smith KH. Leber’s hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol. 1993;111:495–8.

    Article  CAS  PubMed  Google Scholar 

  31. Freeman AG. Optic neuropathy and chronic cyanide intoxication: a review. J R Soc Med. 1988;81:103–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Grzybowski A, Holder GE. Tobacco optic neuropathy (TON) - the historical and present concept of the disease. Acta Ophthalmol. 2011;89:495–9.

    Article  PubMed  Google Scholar 

  33. Behbehani R, Sergott RC, Savino PJ. Tobacco-alcohol amblyopia: a maculopathy? Br J Ophthalmol. 2005;89:1543–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kee C, Hwang J-M. Optical coherence tomography in a patient with tobacco-alcohol amblyopia. Eye (Lond). 2008;22:469–70.

    Article  CAS  Google Scholar 

  35. Moura FC, Monteiro ML. Evaluation of retinal nerve fiber layer thickness measurements using optical coherence tomography in patients with tobacco-alcohol-induced toxic optic neuropathy. Indian J Ophthalmol. 2010;58:143–6.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Grzybowski A. Tobacco amblyopia: does it really exist? Eye (Lond). 2007;21:1448–9.

    Article  CAS  Google Scholar 

  37. Grzybowski A, Pieniazek M. Tobacco-alcohol amblyopia: nonexistent entity. Ind Psychiatry J. 2012;21:79.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Grzybowski A, Pieniążek M. Tobacco-alcohol amblyopia does not exist. Acta Ophthalmol. 2014;92:e77–8.

    Article  PubMed  Google Scholar 

  39. Grzybowski A. Mitochondrial optic neuropathies: additional facts and concepts. Clin Exp Ophthalmol. 2013; https://doi.org/10.1111/ceo.

  40. Grzybowski A, Pieniazek M. Tobacco-alcohol amblyopia—nonexistent entity cannot be diagnosed. J Neurol Sci. 2013;332:156.

    Article  PubMed  Google Scholar 

  41. Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol. 1999;127:610–2.

    Article  CAS  PubMed  Google Scholar 

  42. Martínez-López-Portillo A, Martínez-Gamero BO, Mohamed-Noriega J, Cavazos-Adame H, Mohamed-Hamsho J. Behaviour of disc oedema during and after amiodarone optic neuropathy: case report. J Clin Diagn Res. 2014;8:VD04–5.

    PubMed  PubMed Central  Google Scholar 

  43. Pilania RK, Arora A, Agarwal A, Jindal AK, Aggarwal K, Krishnan G, Suri D, Gupta A, Singh S, Gupta V. Linezolid-induced mitochondrial toxicity presenting as retinal nerve fiber layer microcysts and optic and peripheral neuropathy in a patient with chronic granulomatous disease. Retin Cases Brief Rep. 2018;25 https://doi.org/10.1097/ICB.0000000000000777.

  44. Ishii N, Kinouchi R, Inoue M, Yoshida A. Linezolid-induced optic neuropathy with a rare pathological change in the inner retina. Int Ophthalmol. 2016;36:761–6.

    Article  PubMed  Google Scholar 

  45. David JM, Anupriya A, Sheeja SJ. Presumed chemotherapy-induced optic neuropathy and maculopathy: a case report. Open Ophthalmol J. 2017;11:298–304.

    Article  Google Scholar 

  46. Orssaud C, Roche O, Dufier JL. Nutritional optic neuropathies. J Neurol Sci. 2007;262:158–64.

    Article  CAS  PubMed  Google Scholar 

  47. Sawicka-Pierko A, Obuchowska I, Hady RH, Mariak Z, Dadan J. Nutritional optic neuropathy following bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2014;9(4):662–6.

    PubMed  PubMed Central  Google Scholar 

  48. Becker M, Masterson K, Delavelle J, Viallon M, Vargas ML, Becker CD. Imaging of the optic nerve. Eur J Radiol. 2010;74:299–313.

    Article  PubMed  Google Scholar 

  49. Gratton SM, Lam BL. Visual loss and optic nerve head swelling in thiamine deficiency without prolonged dietary deficiency. Clin Ophthalmol. 2014;8:1021–4.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Pineles SL. Combined optic neuropathy and myelopathy secondary to copper deficiency. Surv Ophthalmol. 2010;55:386–92.

    Article  PubMed  Google Scholar 

  51. Naismith RT, Shepherd JB, Weihl CC, Tutlam NT, Cross AH. Acute and bilateral blindness due to optic neuropathy associated with copper deficiency. Arch Neurol. 2009;66:1025–7.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Spinazzi M, De Lazzari F, Tavolato B, Angelini C, Manara R, Armani M. Myelo-opticoneuropathy in copper deficiency occurring after partial gastrectomy: do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance? J Neurol. 2007;254:1012–7.

    Article  PubMed  Google Scholar 

  53. Woon C, Tang RA, Pardo G. Nutrition and optic nerve disease. Semin Ophthalmol. 1995;10:195–202.

    Article  CAS  PubMed  Google Scholar 

  54. Ahuja S, Kumar PS, Kumar VP, Kattimani S, Akkilagunta S. Effect of chronic alcohol and tobacco use on retinal nerve fiber layer thickness: a case-control study. BMJ Open Ophthalmol. 2016;1:e000003. https://doi.org/10.1136/bmjophth-2016-000003.

  55. Rapoprt Y, Lavin PJM. Nutritional optic neuropathy caused by copper deficiency after bariatric surgery. J Neuroophthalmol. 2016;36:178–81.

    Article  Google Scholar 

  56. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ. 1997;314:180–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology. 1999;106:1792–8.

    Article  CAS  PubMed  Google Scholar 

  58. Lawden MC, Eke T, Degg C, Harding GF, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry. 1999;67:716–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Miller NR, Johnson MA, Paul SR, Girkin CA, Perry JD, Endres M, et al. Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology. 1999;53:2082–7.

    Article  CAS  PubMed  Google Scholar 

  60. Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, et al. Vigabatrin and epilepsy: lessons learned. Epilepsia. 2007;48:1318–27.

    Article  CAS  PubMed  Google Scholar 

  61. Versino M, Veggiotti P. Reversibility of vigabratin-induced visual-field defect. Lancet. 1999;354:486.

    Article  CAS  PubMed  Google Scholar 

  62. Frisen L, Malmgrcn K. Characterization of vigabatrin-associated optic atrophy. Acta Ophthalmol Scand. 2003;81:466–73.

    Article  PubMed  Google Scholar 

  63. Iorga RE, Moraru A, Ozturk MR, Costin D. The role of optical coherence tomography in optic neuropathies. Rom J Ophthalmol. 2018;62:3–14.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Warmia and Mazury, Olsztyn, Poland

    Andrzej Grzybowski

  2. Institute for Research in Ophthalmology, Poznań, Poland

    Andrzej Grzybowski

  3. Department of Ophthalmology, Medical University of Białystok, Białystok, Poland

    Iwona Obuchowska

  4. Department of Ophthalmology, CHU Reims, Reims, France

    Carl Arndt

Authors
  1. Andrzej Grzybowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iwona Obuchowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carl Arndt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Warmia and Mazury, Olsztyn, Poland

    Andrzej Grzybowski

  2. Studio Oculistico d’Azeglio, Bologna, Italy

    Piero Barboni

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Grzybowski, A., Obuchowska, I., Arndt, C. (2020). OCT in Toxic and Nutritional Optic Neuropathies. In: Grzybowski, A., Barboni, P. (eds) OCT and Imaging in Central Nervous System Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-26269-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26269-3_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26268-6

  • Online ISBN: 978-3-030-26269-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation